Drug Safety Act Expands Withdrawal Authority; Final Decision Rests With Commissioner

The proposed FDA Safety Act would enable the Center for Postmarket Drug Evaluation & Research to call for a drug's withdrawal, with final authority retained by the FDA commissioner

More from Archive

More from Pink Sheet